Skip to main content

Research Repository

Advanced Search

Multitarget drug design strategy in Alzheimer’s disease: focus on cholinergic transmission and amyloid-β aggregation

Simioni, Elena; Bartolini, Manuela; Abu, Izuddin Fahmy; Blockley, Alix; Gotti, Cecilia; Bottegoni, Giovanni; Caporaso, Roberta; Bergamini, Christian; Andrisano, Vincenza; Cavalli, Andrea; Mellor, Ian R.; Minarini, Anna

Multitarget drug design strategy in Alzheimer’s disease: focus on cholinergic transmission and amyloid-β aggregation Thumbnail


Authors

Elena Simioni

Manuela Bartolini

Izuddin Fahmy Abu

Alix Blockley

Cecilia Gotti

Giovanni Bottegoni

Roberta Caporaso

Christian Bergamini

Vincenza Andrisano

Andrea Cavalli

Profile Image

IAN MELLOR IAN.MELLOR@NOTTINGHAM.AC.UK
Assistant Professor

Anna Minarini



Abstract

Background: Alzheimer pathogenesis has been associated with a network of processes working simultaneously and synergistically. Over time, much interest has been focused on cholinergic transmission and its mutual interconnections with other active players of the disease. Besides the cholinesterase mainstay, the multifaceted interplay between nicotinic receptors and amyloid is actually considered to have a central role in neuroprotection. Thus, the multitarget drug-design strategy has emerged as a chance to face the disease network. Results: By exploiting the multitarget approach, the present study provides new molecules able to target the cholinergic pathway, by joining direct nicotinic receptor stimulation to acetylcholinesterase inhibition, and to inhibit A? aggregation. Conclusions: These new compounds emerged as a suitable starting point for a further optimization process.

Citation

Simioni, E., Bartolini, M., Abu, I. F., Blockley, A., Gotti, C., Bottegoni, G., …Minarini, A. (in press). Multitarget drug design strategy in Alzheimer’s disease: focus on cholinergic transmission and amyloid-β aggregation. Future Medicinal Chemistry, 9(10), https://doi.org/10.4155/fmc-2017-0039

Journal Article Type Article
Acceptance Date Apr 4, 2017
Online Publication Date Jun 20, 2017
Deposit Date Sep 18, 2017
Publicly Available Date Sep 18, 2017
Journal Future Medicinal Chemistry
Print ISSN 1756-8919
Electronic ISSN 1756-8927
Publisher Future Science
Peer Reviewed Peer Reviewed
Volume 9
Issue 10
DOI https://doi.org/10.4155/fmc-2017-0039
Keywords Alzheimer’s disease, Nicotinic receptors, Acetylcholinesterase inhibitors, Multitarget compounds, Amyloid aggregation.
Public URL https://nottingham-repository.worktribe.com/output/867422
Publisher URL https://www.future-science.com/doi/full/10.4155/fmc-2017-0039

Files






You might also like



Downloadable Citations